LINE OF CREDIT AGREEMENTLine of Credit Agreement • February 16th, 2024 • Nanoviricides, Inc. • Pharmaceutical preparations • Connecticut
THIS LINE OF CREDIT AGREEMENT (“Agreement”) is made and entered into effective as of the 13th day of November, 2023 (“Effective Date”) by and among Anil R. Diwan and/or his successors and assigns (collectively, the “Lender”) and NanoViricides, Inc., a Delaware Corporation (the “Borrower”).
AMENDMENT TO LICENSE AGREEMENTLicense Agreement • February 16th, 2024 • Nanoviricides, Inc. • Pharmaceutical preparations
This AMENDMENT TO LICENSE AGREEMENT (this “Amendment”), dated as of the 13 day of February, 2024 (the “Effective Date”), is entered into by TheraCour Pharma, Inc., a Connecticut corporation (“Licensor”) and NanoViricides, Inc., a Delaware corporation (the “Licensee”). Licensor and Licensee are each referred to herein individually as a “Party” and collectively as the “Parties.”
LINE OF CREDIT EXTENSION AGREEMENTLine of Credit Extension Agreement • February 16th, 2024 • Nanoviricides, Inc. • Pharmaceutical preparations
THIS EXTENSION AGREEMENT (the “Extension”) is dated February 12, 2024 by and between NANOVIRICIDES, INC., a Delaware corporation (“Borrower”), and ANIL R. DIWAN, (“Lender”).
